Loomis, Sayles & Company
VRDN icon

Loomis, Sayles & Company’s Viridian Therapeutics VRDN Stock Holding History

Loomis, Sayles & Company’s Portfolio VRDN Stock Details VRDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$18.7M Sell
1,338,472
-31,884
-2% -$446K 0.02% 250
2025
Q1 		$18.5M Sell
1,370,356
-30,025
-2% -$405K 0.03% 252
2024
Q4 		$26.8M Buy
+1,400,381
New +$26.8M 0.03% 214